drugset / Trial / NCT01153581

Sex Hormones and Orthostatic Tolerance

NCT01153581

Non-randomizedSingle-groupOpen-labelBasic science

Summary

This study is designed to determine the causes of "orthostatic intolerance" which occurs more commonly in women than in men. Orthostatic tolerance is the ability to remain standing up right for long periods of time, or to avoid dizziness when moving to standing from a seated or lying position.

Timeline

Start
2006-02
Primary completion
2012-12
Completion
2013-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Estradiol Other / unclassified 0.2 mg Other
Subject Ganirelix Protein / enzyme biologic 250 ug Subcutaneous
Subject Progesterone Other / unclassified 200 mg Oral

Indications

No indication recorded.